Cedarburg acquires Hauser Pharmaceutical Services
Published: 20-Mar-2009
Newly formed company to be known as Cedarburg Hauser Pharmaceuticals
Cedarburg Pharmaceuticals, a provider of active pharmaceutical ingredients and key intermediates for the pharmaceutical and biopharmaceutical industries, has acquired InB: Hauser Pharmaceutical Services, a contract development manufacturing organization.
The acquisition is believed to strengthen Cedarburg's position in the contract development manufacturing organization market and leverages the synergistic capabilities of both companies to offer clients a more fully-integrated manufacturing platform focused on helping clients move new chemical entities to market.
According to Cedarburg, the newly formed company called Cedarburg Hauser Pharmaceuticals will offer customers a broad range of pharmaceutical services to meet the development and production needs of its clients.
Anthony Laughrey, president and CEO of Cedarburg, said: The acquisition allows us to maximize the true potential of both organizations as one fully integrated contract development and manufacturing organization building value for our shareholders, employees, and customers. The merger will also speed up the development and manufacturing of products currently in our product pipeline.
The new Cedarburg Hauser is well positioned to provide increased efficiency for our clients as they move their critical process development and manufacturing projects through clinical development and ultimately into the commercial arena.
Cedarburg Pharmaceuticals is a commercial and clinical API provider. Cedarburg applies its expertise in process development, validation, Scale-Up and analytical method development.
Hauser is a contract development manufacturing organization dedicated to providing actives and key intermediates to the pharmaceutical and biopharmaceutical industries.
Network Sites

Suppliers To This Sector
Browse A-Z
Solutions4Science
Temperature Mapping and Validation Services ...
Exploristics
Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Sta...
NeuroProof
Screening Services for Pre-Clinical Development of Neuro-Pharmaceuticals and Safety Pharmacology ...
DASGIP
Parallel Bioreactor Systems for the Cultivation of Bacterial, Phototrophic, Animal and Human Cells ...
BioKinetic Europe
Phase I/II Contract Research Organisation ...
Toxikon Europe
CRO Providing Preclinical Safety Studies for the Life Science Community ...
White Papers
Browse A-Z
GRACO's New FDA Pumps
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
GRACO's New Hydra-Clean
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
GRACO's New 1590 & 3150 Pumps
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Customer Testimonial – Astra Zeneca
From the control room to the downstream processing area and with an eye on utilities servi ...
Hygienic Processing
From the control room to the downstream processing area and with an eye on utilities servi ...


Delicious
Digg
Reddit
Stumble
LinkedIn
Mail sent successfully